Valiant Organics Limited — Board Meeting, 22-05-2025: Outcome of Board Meeting

Valiant Organics approved consolidated financial results, reporting ₹7,187.62 Cr revenue and a net loss of ₹34.28 Cr for the year, impacted by a one-time loss of ₹9.16 Cr. EBITDA remained robust at ₹722 Cr. The board reappointed Ketki D. Visariya as Cost Auditor and Manish Modi & Associates as Internal Auditor for FY26. Strategically, Valiant Laboratories has been reclassified from a subsidiary to an associate, signaling a shift in the company’s operational structure.